Related Experiment Video
Updated: Apr 30, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma
Changcun Zhang1, Ren Mo1, Binde Yin1
1Department of Urology, Shanghai First People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, P.R. China.
Abstract:
MicroRNA-34a (miR-34a) is a tumor suppressive microRNA, which induces G1 arrest, apoptosis and senescence by repressing the expression of multiple oncogenes. This study aimed to investigate the biological function and molecular mechanisms of miR-34a in human renal cell carcinoma (RCC) cells. Quantitative polymerase chain reaction (qPCR) revealed that miR-34a expression was significantly downregulated in eight of the 10 (80%) RCC tissues compared with adjacent normal tissues. In RCC cell lines, several other target genes of miR-34a were dysregulated at the mRNA level when the expression of miR-34a was elevated. In addition, western blot analysis and qPCR revealed that forced expression of miR-34a downregulated the expression of Notch1 at the protein and mRNA level. The Cell Counting Kit-8 identified that transient forced expression of miR-34a inhibited cell growth and resulted in cell cycle arrest, which was evaluated by flow cytometry. Our data demonstrated that miR-34a inhibits cell proliferation by downregulating Notch1 in RCC cell lines.
Insights
MicroRNA-34a (miR-34a) is downregulated in renal cell carcinoma (RCC). Its restoration inhibits RCC cell proliferation by targeting Notch1, offering a potential therapeutic strategy for this cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNA-34a (miR-34a) acts as a tumor suppressor by inhibiting oncogenes.
- Renal cell carcinoma (RCC) is a significant health concern with complex molecular underpinnings.
Purpose of the Study:
- To investigate the role and mechanisms of miR-34a in human RCC.
- To determine if miR-34a influences key oncogenic pathways in RCC.
Main Methods:
- Quantitative polymerase chain reaction (qPCR) to assess miR-34a expression levels.
- Western blot analysis and qPCR to evaluate target gene expression (Notch1).
- Cell Counting Kit-8 and flow cytometry to assess cell proliferation and cell cycle arrest.
Main Results:
- miR-34a expression was significantly downregulated in 80% of RCC tissues.
- Forced miR-34a expression reduced Notch1 protein and mRNA levels in RCC cell lines.
- miR-34a overexpression inhibited RCC cell growth and induced cell cycle arrest.
Conclusions:
- miR-34a functions as a tumor suppressor in RCC by downregulating Notch1.
- Restoring miR-34a levels may represent a novel therapeutic approach for renal cell carcinoma.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

